European authorities have backed a targeted BRAF/MEK inhibitor combo for radioactive iodine-refractory thyroid cancer and extended its use to adolescents with advanced or resected melanoma.
Medscape News Europe
Source link : https://www.medscape.com/viewarticle/eu-backs-targeted-braf-combo-melanoma-thyroid-cancer-2026a10009sk?src=rss
Author :
Publish date : 2026-03-31 13:27:00
Copyright for syndicated content belongs to the linked Source.
